Combinating Fingolimod With Alteplase Bridging With Thrombectomy in Acute Ischemic Stroke
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 118 participants.
Also called NCT04675762
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 118 participants
- Sponsor
- Registry
-
NCT04675762
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT04675762. Randomized; quadruple masking; primary purpose treatment. Start 2021-01-15 (actual); primary completion 2025-12-15 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Combinating Fingolimod With Alteplase Bridging With Thrombectomy in Acute Ischemic Stroke
- Condition
- Stroke
- Condition
- Inflammation
- Intervention (Drug)
- Fingolimod
- Intervention (Other)
- Placebo
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Collaborator
- Shaoxing People's Hospital
- Collaborator
- Affiliated Hospital of Jiaxing University
- Collaborator
- Huizhou Municipal Central Hospital
- Collaborator
- The Second Affiliated Hospital of Jiaxing University
- Collaborator
- Jinhua Center Hospital
- Collaborator
- Taizhou Hospital
Record details
- Record id
cardio:ct-nct04675762- Content hash
7b7a81f2474bfa6a497b19e9bf5802c198e77283378cd5389cefefc9d6cb92e6